High performance liquid chromatography evaluation of serum carbohydrate-deficient transferrin and more sialylated transferrin glycoforms in children

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 4, 2012, Pages 274-280

  Bianchi, Vincenza ^a   Raspagni, Alessia ^a   Arfini, Carlo ^a   Vidali, Matteo ^b  

^a Pulmonary Diseases Unit   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Carbohydrate deficient transferring; Children; Congenital disorders of glycosylation; High Performance Liquid Chromatography; Transferrin

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN; DISIALO TRANSFERRIN; MONOSIALO TRANSFERRIN; SIALOPROTEIN; TRISIALO TRANSFERRIN; UNCLASSIFIED DRUG;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CHILD; FEMALE; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; ASIALOGLYCOPROTEINS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSYLATION; HUMANS; INFANT; N-ACETYLNEURAMINIC ACID; PROTEIN PROCESSING, POST-TRANSLATIONAL; REFERENCE VALUES; SIALOGLYCOPROTEINS; TRANSFERRIN;

EID: 84862843702     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.660537     Document Type: Article

References (47)

1. de Jong G, Van Dijk JP, Van Eijk HG. The biology of transferrin.Clin Chim Acta 1990;190:1-46.
2. Van Eijk HG, Van Noort WL, de Jong G, Koster JF. Human serum sialo transferrins in diseases. Clin Chim Acta 1987;165:141-5.
3. FeelDers RA, Vreugdenhil G, de Jong G, Swaak AJ, Van Eijk HG. Transferrin microheterogeneity in rheumatoid arthritis.Relation with disease activity and anemia of chronic disease.Rheumatol Int 1992;12:195-9.
4. Sonmez H, Ozturk ZG, Ulutin T, Domanic N, Kokoglu E.Carbohydrate-defi cient transferrin and sialidase levels in coronary heart disease. Thromb Res 2000;99:311-5.
5. HelanDer A, Bergstrom J, Freeze HH. Testing for congenital disorDers of glycosylation by HPLC measurement of serum transferrin glycoforms. Clin Chem 2004;50:954-8.
6. Bianchi V, Ivaldi A, Raspagni A, Arfi ni C, Vidali M. Pregnancy and variations of carbohydrate-defi cient transferrin levels measured by the candidate reference HPLC method.Alcohol Alcohol 2011;46:123-7.
7. Van Kamp GJ, MulDer K, Kuiper M, Wolters EC. Changed transferrin sialylation in Parkinson's disease. Clin Chim Acta 1995;235:159-67.
8. Van Rensburg SJ, Berman P, Potocnik F, MacGregor P,Hon D, de Villiers N. 5- and 6-glycosylation of transferrin in patients with Alzheimer's disease. Metab Brain Dis 2004;19:89-96.
9. Piagnerelli M, Boudjeltia KZ, Nuyens V, De Backer D, Su F,Wang Z, Vincent JL, Vanhaeverbeek M. Rapid alterationsin transferrin sialylation during sepsis. Shock 2005;24:48-52.
10. Arndt T. Carbohydrate-defi cient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis,and interpretation. Clin Chem 2001;47:13-27.
11. Salaspuro M. Carbohydrate-defi cient transferrin as compared to other markers of alcoholism: a systematic review.Alcohol 1999;19:261-71.
12. Bianchi V, Ivaldi A, Raspagni A, Arfi ni C, Vidali M. Use of carbohydrate-defi cient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffi c medicine. Alcohol Alcohol 2010;45:247-51.
13. Golka K, Wiese A. Carbohydrate-defi cient transferrin (CDT)- a biomarker for long-term alcohol consumption. J Toxicol Environ Health B Crit Rev 2004;7:319-37.
14. HelanDer A, Husa A, Jeppsson JO. Improved HPLC method for carbohydrate-defi cient transferrin in serum. Clin Chem 2003;49:1881-90.
15. Bergstrom JP, HelanDer A. Clinical characteristics of carbohydrate-defi cient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specifi city, genDer effects, and relationship with other alcohol biomarkers. Alcohol Alcohol 2008;43:436-41.
16. Pronicka E, Adamowicz M, Kowalik A, Ploski R, Radomyska B, Rogaszewska M, Rokicki D, Sykut-Cegielska J. Elevated carbohydrate-defi cient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary fructose intolerance and galactosemia. Pediatr Res 2007;62:101-5.
17. Stibler H, von Dobeln U, Kristiansson B, Guthenberg C.Carbohydrate-defi cient transferrin in galactosaemia. Acta Paediatr 1997;86:1377-8.
18. Zamboni G, Bortolotti F, Zaffanello M, De Paoli G, Tagliaro F. Carbohydrate-defi cient transferrin determined in blood microsamples from healthy newborns by using capillary zone electrophoresis. Scand J Clin Lab Invest 2007;67:191-5.
19. Parente F, Ah Mew N, Jaeken J, Gilfi x BM. A new capillary zone electrophoresis method for the screening of congenital disorDers of glycosylation (CDG). Clin Chim Acta 2010;411:64-6.
20. O'Brien JF. Methods for detection of carbohydrate-defi cient glycoprotein syndromes. Semin Pediatr Neurol 2005;12:159-62.
21. Carchon HA, Chevigne R, Falmagne JB, Jaeken J. Diagnosis of congenital disorDers of glycosylation by capillary zone electrophoresis of serum transferrin. Clin Chem 2004;50:101-11.
22. Colome C, Ferrer I, Artuch R, Vilaseca MA, Pineda M, Briones P. Personal experience with the application of carbohydrate- defi cient transferrin (CDT) assays to the detection of congenital disorDers of glycosylation. Clin Chem Lab Med 2000;38:965-9.
23. Viitala K, Lahdesmaki K, Niemela O. Comparison of the Axis %CDT TIA and the CDTect method as laboratory tests of alcohol abuse. Clin Chem 1998;44:1209-15.
24. Delanghe JR, HelanDer A, WielDers JP, Pekelharing JM,Roth HJ, Schellenberg F, Born C, Yagmur E, Gentzer W,Althaus H. Development and multicenter evaluation of the N latex CDT direct immunonephelometric assay for serum carbohydrate-defi cient transferrin. Clin Chem 2007;53:1115-21.
25. HelanDer A, Fors M, Zakrisson B. Study of Axis-Shield new%CDT immunoassay for quantifi cation of carbohydratedefi cient transferrin (CDT) in serum. Alcohol Alcohol 2001;36:406-12.
26. HelanDer A, WielDers JP, Te Stroet R, Bergstrom JP. Comparison of HPLC and capillary electrophoresis for confi rmatory testing of the alcohol misuse marker carbohydrate-defi cient transferrin. Clin Chem 2005;51:1528-31.
27. Tagliaro F, Bortolotti F. Recent adVances in the applications of CE to forensic sciences (2005-2007). Electrophoresis 2008;29:260-8.
28. Lanz C, Kuhn M, Deiss V, Thormann W. Improved capillary electrophoresis method for the determination of carbohydrate- defi cient transferrin in patient sera. Electrophoresis 2004;25:2309-18.
29. del Castillo Busto ME, Montes-Bayon M, Blanco-Gonzalez E, Meija J, Sanz-Medel A. Strategies to study human serum transferrin isoforms using integrated liquid chromatography ICPMS, MALDI-TOF, and ESI-Q-TOF detection: application to chronic alcohol abuse. Anal Chem 2005;77:5615-21.
30. Kleinert P, Kuster T, Durka S, Ballhausen D, Bosshard NU, Steinmann B, Hanseler E, Jaeken J, Heizmann CW,Troxler H. Mass spectrometric analysis of human transferrin in different body fl uids. Clin Chem Lab Med 2003;41:1580-8.
31. Bergstrom JP, HelanDer A. HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-defi cient transferrin (CDT) levels. Clin Chim Acta 2008;389:164-6.
32. Jeppsson JO, Arndt T, Schellenberg F, WielDers JP, Anton RF, Whitfi eld JB, HelanDer A. Toward standardization of carbohydrate-defi cient transferrin (CDT) measurements: I.Analyte defi nition and proposal of a candidate reference method. Clin Chem Lab Med 2007;45:558-62.
33. Coffi n CM, Hamilton MS, Pysher TJ, Bach P, Ashwood E,Schweiger J, Monahan D, Perry D, Rogers BB, Brugnara C,Rutledge J, Weiss R, Ash O, Hill H, Meikle W, Roberts W,Geaghan S. Pediatric laboratory medicine: current challenges and future opportunities. Am J Clin Pathol 2002;117:683-90.
34. Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics 1998;102:E69.
35. Lepage N, Li D, Kavsak PA, Bamforth F, Callahan J, Dooley K, Potter M. Incomplete pediatric reference intervals for the management of patients with inborn errors of metabolism.Clin Biochem 2006;39:595-9.
36. Fuller E. Drug use, smoking and drinking among young people in England in 2007. National Centre for Social Research, National Foundation for Educational Research;2008.
37. HelanDer A, Bergstrom JP. Determination of carbohydratedefi cient transferrin in human serum using the Bio-Rad %CDT by HPLC test. Clin Chim Acta 2006;371:187-90.
38. R Foundation for Statistical Computing. R: A Language and Environment for Statistical Computing (http:///www.Rproject.org). Vienna, Austria; 2009.
39. Kenan N, Larsson A, Axelsson O, HelanDer A. Changes in transferrin glycosylation during pregnancy may lead to falsepositive carbohydrate-defi cient transferrin (CDT) results in testing for riskful alcohol consumption. Clin Chim Acta 2011;412:129-33.
40. Arndt T, Stanzel S, Sewell AC. Paediatric age-dependent serum transferrin isoform distribution studied by HPLC.Clin Lab 2007;53:575-82.
41. Wu Y, Sakamoto H, Kanenishi K, Tanaka S, Ueno M, Hata T.Transferrin microheterogeneity in fetal blood. Biol Neonate 2004;86:98-103.
42. de Jong G, Van Noort WL, FeelDers RA, de Jeu-Jaspars CM,Van Eijk HG. Adaptation of transferrin protein and glycan synthesis. Clin Chim Acta 1992;212:27-45.
43. N agaoka MH, Maitani T. Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS. Biochim Biophys Acta 2001;1526:175-82.
44. Lacey JM, Bergen HR, Magera MJ, Naylor S, O'Brien JF.Rapid determination of transferrin isoforms by immunoaffi nity liquid chromatography and electrospray mass spectrometry. Clin Chem 2001;47:513-8.
45. Callewaert N, Schollen E, Vanhecke A, Jaeken J, Matthijs G,Contreras R. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorDer of glycosylation I. Glycobiology 2003;13:367-75.
46. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate defi cient glycoprotein syndrometype II: a defi ciency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994;71:123-7.
47. Bergstrom JP, HelanDer A. Infl uence of alcohol use, ethnicity,age, genDer, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydratedefi cient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 2008;388:59-67.